Company Filing History:
Years Active: 2021
Title: Ju Hyeon Lee: Innovator in Cancer Research
Introduction
Ju Hyeon Lee is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of cancer research, particularly through her innovative work on indolinone derivatives.
Latest Patents
Ju Hyeon Lee holds a patent for "Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase." This patent focuses on indolinone compounds, compositions, and methods for inhibiting maternal embryonic leucine zipper kinase (MELK). The research also explores the potential of these compounds in the treatment or prevention of cancers, including triple-negative breast cancer. She has 1 patent to her name.
Career Highlights
Ju Hyeon Lee is affiliated with the University of Texas System, where she continues her research and development in the field of cancer therapeutics. Her work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Collaborations
Some of her notable coworkers include Kevin N Dalby and Ramakrishna Edupuganti, who have collaborated with her on various research projects.
Conclusion
Ju Hyeon Lee's innovative contributions to cancer research exemplify her dedication to improving healthcare outcomes. Her work on indolinone derivatives showcases the potential for new therapeutic approaches in the fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.